Polymyalgia rheumatica, temporal arteritis and malignancy.
The use of steroid therapy in polymyalgia rheumatica and temporal arteritis is necessary and usually effective, but may mask coexisting disease. The importance of early consideration of other disorders in such patients is illustrated by three case histories.
Speed
C A
CA
Department of Rheumatology, South Cleveland Hospital, Middlesbrough, Cleveland, UK.
Haslock
I
I
D000230:Adenocarcinoma / Q000150:complications*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000150:complications*; D005260:Female; D013700:Giant Cell Arteritis / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications*; D008297:Male; D008875:Middle Aged; D011111:Polymyalgia Rheumatica / Q000150:complications* / Q000188:drug therapy; D011239:Prednisolone / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D011239:Prednisolone